Galenea's Grant - III Round

Galenea raised a round of funding on October 12, 2010. Investors include National Institute of Mental Health.

Galenea is a biopharmaceutical company discovering and developing drugs to treat schizophrenia and other central nervous system diseases. The company has developed technology, the MANTRA (Multiwell, A…

Articles about Galenea's Grant - III Round: